The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group

Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
Her collection, “To See Yourself As You Vanish,” will be published three years after her death

Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust

When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025

Cancer Policy

ACOG says it will no longer accept federal funding

Trump administration broke law by canceling DEI research grants, GAO finds

HHS halts nearly $500M in mRNA-related vaccine contracts

Brown University reaches agreement with Trump administration to restore funding

All federal grants must be reviewed by Trump appointees, executive order directs

UPenn study supports continued use of ODAC voting

Clinical Roundup

Mailing at-home test kits is more effective at getting younger adults to participate in CRC screening, UCLA study finds

In phase III trial, epcoritamab regimen improves PFS in R/R follicular lymphoma

Cannabis use disorder triples risk of oral cancer, UCSD study finds

Blood tests show potential for CRC detection, but follow-up falls short

IGRT shows no reduction in serious infections for patients with CLL

Respiratory viruses can wake up breast cancer cells in lungs, preclinical study shows

In The Clinic

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI

An overlooked immune cell population may offer new direction for cell and gene therapy

She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research

How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest

Latest Issue

NEWS ALERTS

Stay up to date on the latest news in oncology by joining our mailing list.

UPCOMING EVENTS

Sep 2025

Oct 2025

Conversations with The Cancer Letter

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James

Contributors

Barnett Kramer, MD, MPH

Richard T. Lee, MD

Jeff Sorenson

Robert Peter Gale, MD, PhD, DSc (hon), FACP, FRCP, FRCPI(hon), FRSM

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group

Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
Her collection, “To See Yourself As You Vanish,” will be published three years after her death

Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust

When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025

ACOG says it will no longer accept federal funding

Trump administration broke law by canceling DEI research grants, GAO finds

HHS halts nearly $500M in mRNA-related vaccine contracts

Brown University reaches agreement with Trump administration to restore funding

All federal grants must be reviewed by Trump appointees, executive order directs

UPenn study supports continued use of ODAC voting

Mailing at-home test kits is more effective at getting younger adults to participate in CRC screening, UCLA study finds

In phase III trial, epcoritamab regimen improves PFS in R/R follicular lymphoma

Cannabis use disorder triples risk of oral cancer, UCSD study finds

Blood tests show potential for CRC detection, but follow-up falls short

IGRT shows no reduction in serious infections for patients with CLL

Respiratory viruses can wake up breast cancer cells in lungs, preclinical study shows

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI

An overlooked immune cell population may offer new direction for cell and gene therapy

She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research

How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James

Barnett Kramer, MD, MPH

Richard T. Lee, MD

Jeff Sorenson

Robert Peter Gale, MD, PhD, DSc (hon), FACP, FRCP, FRCPI(hon), FRSM

Never miss an issue!

Login

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five statesHonoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

HHS seems poised to exert control over USPSTFRansohoff: The task force is the pinnacle of evidence-based medicine

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James

Never miss an issue!

Login

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine